Genentech Overview

  • Founded
  • 1976
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 15,000
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Latest Deal Amount
  • $46.8B
Latest Deal Amount

Genentech General Information

Description

Discoverer, developer and manufacturer of pharmaceutical products focusing on immunology and oncology medical fields. The company offers pharmaceutical products that have applications in ophthalmology, metabolism, and virology fields and includes Lucentis, a ranibizumab injection for the treatment of diabetic macular edema, and ACTEMRA (tocilizumab) for the treatment of adults with moderately to severely active rheumatoid arthritis.

Contact Information

Website
www.gene.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Parent Company
Primary Office
  • 1 DNA Way
  • South San Francisco, CA 94080
  • United States
+1 (650) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genentech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 12-Mar-2009 $46.8B 00000 Completed Generating Revenue
5. 2PO 20-Jul-1999 Completed Generating Revenue
4. Merger/Acquisition 17-Jun-1999 00.00 000.00 000.00 Completed Generating Revenue
3. IPO 14-Oct-1980 0000 000.00 Completed Generating Revenue
2. Early Stage VC 17-Oct-1979 $10M $10.2M Completed Generating Revenue
1. Early Stage VC 01-Jan-1976 $200K $200K Completed Generating Revenue
To view Genentech’s complete valuation and funding history, request access »

Genentech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Discoverer, developer and manufacturer of pharmaceutical products focusing on immunology and oncology medical fields. Th
Biotechnology
South San Francisco, CA
15,000 As of 2020
000.00
0000 0000-00-00
00000000000

0000000

, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut
000000000000000
Boston, MA
0000 As of 0000
000 0000-00-00
000000&0

00000000

magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000 000000000
New York, NY
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genentech Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Alexion Formerly VC-backed Boston, MA 0000 000000&0
000000000(00000000 Formerly VC-backed New York, NY 000 00000 000000 - 000 00000
00000000 000000000 Formerly VC-backed South San Francisco, CA 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Newark, CA 00 00000 00000000 00000
000 00000000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000000 00000
You’re viewing 5 of 39 competitors. Get the full list »

Genentech Executive Team (45)

Name Title Board Seat Contact Info
Alexander Hardy Chief Executive Officer & Board Member
Ed Harrington Chief Financial Officer
Jayson Johnson Senior Principal Talent Discovery Partner - Diversity Lead
Rekha Vaidyanathan Senior Project Manager and Principal Program Manager
Joel Vidal-Phillips Principal
You’re viewing 5 of 45 executive team members. Get the full list »

Genentech Board Members (7)

Name Representing Role Since
Alexander Hardy Genentech Chief Executive Officer & Board Member 000 0000
You’re viewing 1 of 7 board members. Get the full list »

Genentech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genentech Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ignite 500 Venture Capital Minority 000 0000 000000 0
Kleiner Perkins Venture Capital Minority 000 0000 000000 0
Lubrizol Corporation Minority 000 0000 000000 0
Mayfield (Private Equity) Venture Capital Minority 000 0000 000000 0
To view Genentech’s complete investors history, request access »

Genentech Investments & Acquisitions (34)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 11-Jan-2021 00000 00000 00 00000 Biotechnology
000 11-Sep-2019 000000000000000000 Diagnostic Equipment
000000 00000000000 16-May-2019 000000000 Pharmaceuticals
00000 00000 23-Apr-2019 0000 00000 Specialized Finance
Jecure Therapeutics 28-Nov-2018 Merger/Acquisition Drug Discovery 00000 00000
You’re viewing 5 of 34 investments and acquisitions. Get the full list »

Genentech Subsidiaries (1)

Company Name Industry Location Founded
000 Diagnostic Equipment Dallas, TX 0000
To view Genentech’s complete subsidiaries history, request access »

Genentech Exits (20)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000000 16-Jul-2015 00000 00000 00 00000 Completed
  • 11 buyers
0000000000000 0000 05-Aug-2014 00000 00000 00 000 Completed
  • 5 buyers
0000000000000 0000 01-Jan-2012 00000 00000 00 0000 Completed
  • 000000000
000000000 04-Feb-2009 00000 00000 00 000.00 Completed
  • 5 buyers
Tolerx 30-Oct-2007 Later Stage VC 0000 Completed
  • 8 buyers
You’re viewing 5 of 20 exits. Get the full list »